Literature DB >> 15498867

A systematic method for identifying small-molecule modulators of protein-protein interactions.

Alexander R Horswill1, Sergey N Savinov, Stephen J Benkovic.   

Abstract

Discovering small-molecule modulators of protein-protein interactions is a challenging task because of both the generally noncontiguous, large protein surfaces that form these interfaces and the shortage of high-throughput approaches capable of identifying such rare inhibitors. We describe here a robust and flexible methodology that couples disruption of protein-protein complexes to host cell survival. The feasibility of this approach was demonstrated through monitoring a small-molecule-mediated protein-protein association (FKBP12-rapamycin-FRAP) and two cases of dissociation (homodimeric HIV-1 protease and heterodimeric ribonucleotide reductase). For ribonucleotide reductase, we identified cyclic peptide inhibitors from genetically encoded libraries that dissociated the enzyme subunits. A solid-phase synthetic strategy and peptide ELISAs were developed to characterize these inhibitors, resulting in the discovery of cyclic peptides that operate in an unprecedented manner, thus highlighting the strengths of a functional approach. The ability of this method to process large libraries, coupled with the benefits of a genetic selection, allowed us to identify rare, uniquely active small-molecule modulators of protein-protein interactions at a frequency of less than one in 10 million.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498867      PMCID: PMC524857          DOI: 10.1073/pnas.0406999101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Production of cyclic peptides and proteins in vivo.

Authors:  C P Scott; E Abel-Santos; M Wall; D C Wahnon; S J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 2.  Antagonists of protein-protein interactions.

Authors:  A G Cochran
Journal:  Chem Biol       Date:  2000-04

3.  A bacterial two-hybrid selection system for studying protein-DNA and protein-protein interactions.

Authors:  J K Joung; E I Ramm; C O Pabo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

4.  Genetic selection for dissociative inhibitors of designated protein-protein interactions.

Authors:  S H Park; R T Raines
Journal:  Nat Biotechnol       Date:  2000-08       Impact factor: 54.908

5.  Two-hybrid system for characterization of protein-protein interactions in E. coli.

Authors:  L B Hays; Y S Chen; J C Hu
Journal:  Biotechniques       Date:  2000-08       Impact factor: 1.993

6.  A two-hybrid system based on chimeric operator recognition for studying protein homo/heterodimerization in Escherichia coli.

Authors:  G Di Lallo; L Castagnoli; P Ghelardini; L Paolozzi
Journal:  Microbiology       Date:  2001-06       Impact factor: 2.777

7.  Affinity-driven selection of tripeptide inhibitors of ribonucleotide reductase.

Authors:  Ying Gao; Sebastian Liehr; Barry S Cooperman
Journal:  Bioorg Med Chem Lett       Date:  2002-02-25       Impact factor: 2.823

8.  Toward a rational design of peptide inhibitors of ribonucleotide reductase: structure-function and modeling studies.

Authors:  B A Pender; X Wu; P H Axelsen; B S Cooperman
Journal:  J Med Chem       Date:  2001-01-04       Impact factor: 7.446

9.  Structural requirements for the biosynthesis of backbone cyclic peptide libraries.

Authors:  C P Scott; E Abel-Santos; A D Jones; S J Benkovic
Journal:  Chem Biol       Date:  2001-08

10.  Structure-based optimization of peptide inhibitors of mammalian ribonucleotide reductase.

Authors:  M Pellegrini; S Liehr; A L Fisher; P B Laub; B S Cooperman; D F Mierke
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

View more
  31 in total

Review 1.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Ribosomal Synthesis of Macrocyclic Peptides in Vitro and in Vivo Mediated by Genetically Encoded Aminothiol Unnatural Amino Acids.

Authors:  John R Frost; Nicholas T Jacob; Louis J Papa; Andrew E Owens; Rudi Fasan
Journal:  ACS Chem Biol       Date:  2015-05-15       Impact factor: 5.100

3.  Ribosomal Synthesis of Natural-Product-Like Bicyclic Peptides in Escherichia coli.

Authors:  Nina Bionda; Rudi Fasan
Journal:  Chembiochem       Date:  2015-08-06       Impact factor: 3.164

4.  Potential pharmacological chaperones targeting cancer-associated MCL-1 and Parkinson disease-associated α-synuclein.

Authors:  Misook Oh; Ji Hoon Lee; Wei Wang; Hui Sun Lee; Woo Sirl Lee; Christopher Burlak; Wonpil Im; Quyen Q Hoang; Hyun-Suk Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

5.  A promiscuous split intein with expanded protein engineering applications.

Authors:  Adam J Stevens; Giridhar Sekar; Neel H Shah; Anahita Z Mostafavi; David Cowburn; Tom W Muir
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-24       Impact factor: 11.205

Review 6.  Macrocycles as protein-protein interaction inhibitors.

Authors:  Patrick G Dougherty; Ziqing Qian; Dehua Pei
Journal:  Biochem J       Date:  2017-03-15       Impact factor: 3.857

Review 7.  Synthetic biology approaches in drug discovery and pharmaceutical biotechnology.

Authors:  Heinz Neumann; Petra Neumann-Staubitz
Journal:  Appl Microbiol Biotechnol       Date:  2010-04-16       Impact factor: 4.813

8.  Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models.

Authors:  Joshua A Kritzer; Shusei Hamamichi; J Michael McCaffery; Sandro Santagata; Todd A Naumann; Kim A Caldwell; Guy A Caldwell; Susan Lindquist
Journal:  Nat Chem Biol       Date:  2009-07-13       Impact factor: 15.040

Review 9.  "Splicing up" drug discovery. Cell-based expression and screening of genetically-encoded libraries of backbone-cyclized polypeptides.

Authors:  Harshkumar Sancheti; Julio A Camarero
Journal:  Adv Drug Deliv Rev       Date:  2009-07-21       Impact factor: 15.470

Review 10.  Features of protein-protein interactions that translate into potent inhibitors: topology, surface area and affinity.

Authors:  Matthew C Smith; Jason E Gestwicki
Journal:  Expert Rev Mol Med       Date:  2012-07-26       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.